Journal Article

Folate as a potential treatment for lethal ventricular arrhythmias in TANGO2-deficiency disorder

Horrigan, Frank T., Yu, Andy C., Li, Na, Altamirano, Francisco, Xu, Weiyi, Zhang, Lilei, Kim, Jean J., Wehrens, Xander H.T., Arredondo, Maria Jose, Stephens, Sara B., Perez, William, Cao, Yingqiong, Chen, Yifan, Sun, Liang, Lalani, Seema R., Miyake, Christina Y.

2024

Overview

TANGO2-deficiency disorder (TDD) is an autosomal-recessive genetic disease caused by biallelic loss-of-function variants in the TANGO2 gene. TDD-associated cardiac arrhythmias are recalcitrant to standard antiarrhythmic medications and constitute the leading cause of death. Disease modeling for TDD has been primarily carried out using human dermal fibroblast and, more recently, in Drosophila by multiple research groups. No human cardiomyocyte system has been reported, which greatly hinders the investigation and understanding of TDD-associated arrhythmias. Here, we established potentially novel patient-derived induced pluripotent stem cell differentiated cardiomyocyte (iPSC-CM) models that recapitulate key electrophysiological abnormalities in TDD. These electrophysiological abnormalities were rescued in iPSC-CMs with either adenoviral expression of WT-TANGO2 or correction of the pathogenic variant using CRISPR editing. Our natural history study in patients with TDD suggests that the intake of multivitamin/B complex greatly diminished the risk of cardiac crises in patients with TDD. In agreement with the clinical findings, we demonstrated that high-dose folate (vitamin B9) virtually abolishes arrhythmias in TDD iPSC-CMs and that folate's effect was blocked by the dihydrofolate reductase inhibitor methotrexate, supporting the need for intracellular folate to mediate antiarrhythmic effects. In summary, data from TDD iPSC-CM models together with clinical observations support the use of B vitamins to mitigate cardiac crises in patients with TDD, providing potentially life-saving treatment strategies during life-threatening events.

• Publisher: American Society for Clinical Investigation,American Society for Clinical investigation
• Subject: Antiarrhythmics / Arrhythmia / Arrhythmias, Cardiac - drug therapy / Arrhythmias, Cardiac - genetics / Cardiac arrhythmia / Cardiology / Cardiomyocytes / Cell culture / Cell differentiation / Child / CRISPR / Deficiency diseases / Dihydrofolate reductase / Electrocardiography / Female / Folic acid / Folic Acid - metabolism / Folic Acid - therapeutic use / Genetic disorders / Genetics / Humans / Induced Pluripotent Stem Cells - metabolism / Male / Metabolism / Methotrexate / Mortality / Mutation / Myocytes, Cardiac - metabolism / Myocytes, Cardiac - pathology / Patients / Peptides / Pluripotency / Polyclonal antibodies / Proteins / Stem cells / Vitamin B / Vitamins